Similar Articles
Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study
Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai
DOI: 10.46497/ArchRheumatol.2024.10418
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2024.10199
Lung involvement in patients with psoriatic arthritis
Mehmet Hünür, Tahir Saygın Öğüt, Ece Çelik, Funda Erbasan, Melis Dilbil, Mine Nokay, Mustafa Ender Terzioğlu, Veli Yazisiz
DOI: 10.46497/ArchRheumatol.2024.10537
Association of Health-Related Quality of Life with Functional and Radiological Outcomes in Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease, Systemic Sclerosis–Associated Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis
Irem Sahinoğlu, Deniz Kizilirmak, Sadettin Uslu, Mevlüt Kacar, Filiz Cemre Tasgöz, Seref Sülükcü, Emre Ali Acar, Müge Gencer Tuluy, Secil Sari, Ozgül Soysal Gündüz, Timur Pirildar
DOI: 10.5152/ArchRheumatol.2025.11105
Correlation of Pleural and Pulmonary Ultrasound with the Severity of Autoimmune Interstitial Lung Disease
Luis Javier Cajas Santana, Satiago Cuero, Gabriela Guerrero, Mayelin Ceballos, María Carolina Torres Villarreal
DOI: 10.5152/ArchRheumatol.2025.10999
Exosomal microRNAs in Different Disease Activity Status in Systemic Lupus Erythematosus: A Retrospective Study
Wenyu Xu,Peiying Nie,Qian Li,Bingjie Gu, Qijie Ren,Xingguo Chen
DOI: 10.5152/ArchRheumatol.2025.11027
Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang
DOI: 10.5152/ArchRheumatol.2025.25013